Last updated: 2026-10-13 10:25:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Sera Prognostics, Inc. (SERA) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $2.07, with a market capitalisation of $80.48M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.56 to $3.95. This page covers its latest market performance, valuation, price trends and company information.
$80.48M | |
$2.07 | |
$15.50 | |
$1.10 | |
$2.07 | |
-- | |
27.03K | |
-- | |
$3.95 | |
$1.56 | |
-- | |
-- |
Sera Prognostics, Inc. (SERA) is trading at $2.07 in pre-market trading as of 2026-10-13 08:03:00, down 0.14% ($0.00) from the previous close of $2.07
Pre-market trading shows how investors are pricing SERA before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, Sera Prognostics, Inc. (SERA) moved from $2.09 to $2.07, representing a decline of 1.10% ($0.02).
The stock traded between $2.00 and $2.21 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 11.92 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 21.2%
SERA is currently trading at $2.07, placing it 21.2% of the way from its 52-week low of $1.56 to its 52-week high of $3.95. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 72 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Sera Prognostics, Inc. (SERA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.